LOGIN
ID
PW
MemberShip
2024-12-13 03:03
All News
Policy
Company
Product
Opinion
InterView
검색
Dailypharm Live Search
Close
Managed Entry Agreements for
Managed Entry Agreements for
Oncology Drugs
Input Time : 2019-11-15
[Download file]
go back
OPINION
[Reporter's View] Restricting vs expanding access
Reporter's view |
Eo, Yun-Ho
[Reporter's View] what 'AI-driven drug discovery' requires
Reporter's view |
Kim, Jin-Gu
[Desk's View] Re-evaluation of eye drops
Desk's view |
Lee, Tak-Sun
INTERVIEW
‘3 IBD treatment trends…early treatment is the first’
For inflammatory bowel disease
‘Improve new drug access to treat rheumatoid arthritis'
to fundamentally treat the disease, not just its symptoms
'Early detection of RA can help prevent severe symptoms'
"Recruiting a company to co-develop pitavastatin+ezetimibe"
Seung Hee Baek, Shinil Pharmaceutical's Executive Director
"JAK inhibitors bring a paradigm shift to RA treatment"
Data
Roche 2018 Annualreport
Roche 2018 Annualreport
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
2018 Multinational Pharma Sales
2018 Multinational Pharma Sales
MOST READ
1
Antibiotic clarithromycin market grows fourfold in 3 yrs
2
1st MET-targeting anticancer drug likely to get reimb in KOR
3
'Lalaola' wins 2024 Pharma Industry ad grand prize
4
MM drug Revlimid continues to thrive after patent expiry
5
‘Pluvicto, a new standard therapy for prostate cancer?'
6
'Effective in Asian patients' Leclaza vs Tagrisso comb
7
Lilly will directly distribute Trulicity in Korea next year
8
Jemperli expands indication to all endometrial cancers
9
New drug approval fee to rise next year
10
NeuroBiogen enters into Binding Term Sheet with US Company
